Alteration of m6A Methylation in Breast Cancer Cells by Kalanchoe pinnata Aqueous Extract
- PMID: 40572597
- PMCID: PMC12195708
- DOI: 10.3390/molecules30122634
Alteration of m6A Methylation in Breast Cancer Cells by Kalanchoe pinnata Aqueous Extract
Abstract
Kalanchoe pinnata is used in traditional medicine to treat cancer, as it contains flavonoids and phenols known to regulate key cellular processes associated with cancer. Breast cancer, the most common cancer among women globally, presents ongoing challenges in treatment. The discovery of m6A methylation and its regulation by methylosome proteins offers novel therapeutic avenues for cancer management. This study aimed to investigate the cytotoxic and epitranscriptomic effects of an aqueous extract from K. pinnata on MCF-7 (luminal A) and HCC1937 (triple-negative) breast cancer cells. Cell lines were treated with the aqueous K. pinnata extract, characterized by HPLC, for 72 h, followed by an assessment of cytotoxicity and migration. The expression of methylosome components METTL3 and FTO was measured using RT-PCR. m6A global methylation was assessed via colorimetry, and molecular docking studies were conducted. The results indicated that only HCC1937 cells exhibited altered migration capacity. This change was correlated in silico with the inhibition of METTL3 by luteolin and quercetin, constituents of the aqueous extract. METTL3, a methyltransferase, was overexpressed by scratch stimuli but was downregulated following K. pinnata treatment in both MCF-7 and HCC1937 cells. The FTO demethylase was overexpressed in both cell lines. In silico analysis suggested an interaction between FTO and compounds such as gallic acid and myricetin. Additionally, m6A global methylation decreased in MCF-7 cells but increased in HCC1937 cells, potentially affecting cell migration. Our findings indicate that K. pinnata influences both METTL3 and FTO, altering m6A methylation in a cell-type-dependent manner, with HCC1937 cells being particularly sensitive. Further research is required to elucidate the complete molecular mechanism of K. pinnata's aqueous extract in breast cancer treatment.
Keywords: FTO; HCC1937 cells; Kalanchoe pinnata; MCF-7 cells; METTL3; breast cancer; m6A; migration.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures





Similar articles
-
Transcriptome Analysis of Triple-Negative HCC1937 and MDA-MB-231 Breast Cancer Cells Treated with Revealed the Regulation of Migration and Invasion via the Downregulation of the Genes JAK2, ROCK1 and ROCK2.ACS Omega. 2025 Jul 9;10(28):31187-31200. doi: 10.1021/acsomega.5c05895. eCollection 2025 Jul 22. ACS Omega. 2025. PMID: 40727786 Free PMC article.
-
Integrated Nanopore and short-read RNA sequencing identifies dysregulation of METTL3- m6A modifications in endocrine therapy- sensitive and resistant breast cancer cells.Funct Integr Genomics. 2025 Jul 9;25(1):149. doi: 10.1007/s10142-025-01658-2. Funct Integr Genomics. 2025. PMID: 40632306 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Role of N6-methyladenosine methylation in transverse aortic constriction-induced cardiac fibrosis: insights from MeRIP-seq analysis.Mol Biol Rep. 2025 Aug 26;52(1):850. doi: 10.1007/s11033-025-10940-2. Mol Biol Rep. 2025. PMID: 40856860 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
Cited by
-
Transcriptome Analysis of Triple-Negative HCC1937 and MDA-MB-231 Breast Cancer Cells Treated with Revealed the Regulation of Migration and Invasion via the Downregulation of the Genes JAK2, ROCK1 and ROCK2.ACS Omega. 2025 Jul 9;10(28):31187-31200. doi: 10.1021/acsomega.5c05895. eCollection 2025 Jul 22. ACS Omega. 2025. PMID: 40727786 Free PMC article.
References
-
- Rajsekhar P., Bharani R., Ramachandran M., Angel K., Rajsekhar S. The “Wonder Plant” Kalanchoe pinnata (Linn.) Pers.: A Review. J. Appl. Pharm. Sci. 2016;6:151–158. doi: 10.7324/JAPS.2016.60326. - DOI
-
- Allorge-Boiteau L. Madagascar Centre de Speciation et D’origine du Genre Kalanchoe (Crassulaceae) Biogéographie Madagasca. 1996:137–145.
-
- Fernandes J.M., Cunha L.M., Azevedo E.P., Lourenço E.M.G., Fernandes-Pedrosa M.F., Zucolotto S.M. Kalanchoe laciniata and Bryophyllum pinnatum: An updated review about ethnopharmacology, phytochemistry, pharmacology and toxicology. Rev. Bras. Farmacogn. 2019;29:529–558. doi: 10.1016/j.bjp.2019.01.012. - DOI
-
- Elufioye T.O., Oyedeji A.O., Habtemariam S. A Review of the Traditional Uses, Phytochemistry and Pharmacology of Bryophyllum pinnatum (Lam.) (Crassulaceae) J. Biol. Act. Prod. Nat. 2022;12:190–222. doi: 10.1080/22311866.2021.1988706. - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical